Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
Participants in this research study are asked to tell about their experience with art therapy. Participants in this research study are currently receiving chemotherapy treatment for cancer. The purpose of this study is to learn how art therapy affects mood, anxiety, pain, and emotions of individuals with cancer who are undergoing chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
January 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2017
CompletedJanuary 26, 2017
January 1, 2017
9 months
January 14, 2016
January 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The effect of art therapy on the cancer patient's mood
The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.
Change from baseline to after intervention, about 50 minutes
The effect of art therapy on the cancer patient's anxiety
The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.
Change from baseline to after intervention, about 50 minutes
The effect of art therapy on the cancer patient's pain
The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.
Change from baseline to after intervention, about 50 minutes
Secondary Outcomes (9)
exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and ethnic group of patients
Change from baseline to after intervention, about 50 minutes
exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and race of patients
Change from baseline to after intervention, about 50 minutes
exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and age of patients
Change from baseline to after intervention, about 50 minutes
exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and sex of patients
Change from baseline to after intervention, about 50 minutes
exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and caregiver support of patients
Change from baseline to after intervention, about 50 minutes
- +4 more secondary outcomes
Study Arms (1)
Art Therapy
EXPERIMENTALThe art therapy intervention will be executed by an art therapist at the Cancer Center. The same art therapy practices that are utilized in daily practice will be employed in this study. The intervention will include assessment of patient's needs and goals in addition to utilization of various art modalities. Sessions will conclude with processing of the art and supportive counseling as appropriate. Pilot testing of the intervention has been performed informally at Maroone Cancer Center with positive feedback provided by patients and their support systems to the physicians, nurses, and art therapist. Change in pain, emotional distress, depression, adn anxiety will be measured by the emotions thermometer.
Interventions
The Emotions Thermometer, was chosen to assess patients' mood, anxiety level, and pain scale for this study. For patient ease, the study team chose to utilize a scale of 1-10 for all subjective measurements to be obtained from patients (mood and anxiety level). The study team included the thermometer image to mirror the NCCN Guidelines Version Distress Management Screening tool, for measuring distress and mood level. This screening tool has been shown to be effective in assessing patient distress and mood in oncology patients with ease of use in patients and utility in providers.
Each participant will participate in a private art therapy session with the Art Therapist for 50 minutes. The participant will have a choice of materials to work with, including painting, drawing, clay, and collage materials. The session will conclude with processing of the art and supportive counseling.
Eligibility Criteria
You may qualify if:
- Subjects are able to give informed consent
- Any cancer diagnosis
- Actively undergoing any chemotherapy treatment at Maroone Cancer Center
- Patients who have never utilized art therapy at Maroone Cancer Center
- Speaks, reads, and writes in English
- Able and willing to participate in an art therapy session at Maroone Cancer Center
You may not qualify if:
- Patients without cancer diagnosis
- Patients not actively undergoing chemotherapy at Maroone Cancer Center
- Individuals unable to complete art therapy activities independently due to physical and/or mental impairment
- Under 18 years of age (minors)
- Patients who have dementia or a legal guardian
- Unable to speak, read, and write in English
- Patients who have previously utilized art therapy at Maroone Cancer Center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maroone Cancer Center - Cleveland Clinic Florida
Weston, Florida, 33331, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Roshon, MD
Cleveland Clinic Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2016
First Posted
January 20, 2016
Study Start
May 1, 2015
Primary Completion
January 25, 2016
Study Completion
January 25, 2017
Last Updated
January 26, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share